Profile
Brent J.
Warner is currently Chief Executive Officer & Director at Protego Biopharma, Inc. since 2024.
Formerly, Mr. Warner was President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024 and Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
Mr. Warner completed undergraduate and MBAistration degrees at Northwood University (Michigan).
Brent Warner active positions
| Companies | Position | Start |
|---|---|---|
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Chief Executive Officer | 01/04/2024 |
Former positions of Brent Warner
| Companies | Position | End |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2024 |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/02/2022 |
Training of Brent Warner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Northwood University (Michigan)
Northwood University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
- Stock Market
- Insiders
- Brent Warner
















